| [1] |
Robert T, Berthelot L, Cambier A，et al.Molecular insights into the pathogenesis of IgA nephropathy[J]．Trends Mol Med，2015，21(12)：762-775.
|
| [2] |
Mestecky J, Raska M, Julian BA, et al.IgA nephropathy：molecular mechanisms of the disease[J]．Annu Rev Pathol, 2013, 8(1): 217-240.
|
| [3] |
Pabst O．New concepts in the generation and functions of IgA[J]．Nat Rev Immunol，2012，12(12)：821-832.
|
| [4] |
Zhao N, Hou P, Lv J，et al.The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression[J]．Kidney Int，2012，82(7)：790-796.
|
| [5] |
Placzek WJ, Yanagawa H, Makita Y, et al. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy[J]. PLoS One, 2018, 13(1): e0190967.
|
| [6] |
Zhang C, Zeng X, Li Z，et al. Immunoglobulin A nephropathy：current progress and future directions[J]. Transl Res，2015，166(2)：134-144.
|
| [7] |
Suzuki H, Yasutake J, Makita Y, et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis[J]. Kidney Int, 2018, 93(3): 700-705.
|
| [8] |
Suzuki H, Raska M, Yamada K，et al.Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-Ⅱ enzymes[J]．J Biol Chem, 2014, 289(8): 5330-5339.
|
| [9] |
Malycha F, Eggermann T, Hristov M．No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients[J]．Nephrol Dial Transplant, 2009, 24(1): 321-324.
|
| [10] |
Sun Q, Zhang J, Zhou N，et al. DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy[J]. PLoS One，2015，10(2)：e0112305.
|
| [11] |
Takahashi K, Raska M, Stuchlova Horynova M, et al. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy [J]. PLoS One, 2014, 9(6): e99026.
|
| [12] |
Steirer LM, Park EI, Townsend RR, et al.The asialoglycoprotein receptor regulates levels of plasma glycoproteins terminating with sialic acid a2 , 6-galactose[J]．J Biol Chem, 2009, 284(6): 3777-3783.
|
| [13] |
Al-Lawati Ali I, Reich Heather N. Is there a role for immunosuppression in immunoglobulin A nephropathy？[J]．Nephrol Dial Transplant, 2017, 32(Suppl 1): i30-i36.
|
| [14] |
Wyatt RJ, Julian BA. IgA nephropathy[J]. N Engl J Med，2013，368(25)：2402-2414.
|
| [15] |
Potter CS, Wang Z, Silva KA，et al. Chronic proliferative dermatitis in Sharpin null mice : development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling[J]．PLoS One，2014，9(1)：e85666.
|
| [16] |
Liu Y, Liu H, Peng Y, et al. New insights into the pathogenesis of IgA nephropathy: do toll like receptor 9-B cell activation factor-IgA class switching recombination signaling axis induce IgA hyper-production？[J]. Ren Fail, 2014, 36(6): 970-973.
|
| [17] |
Nakata J, Suzuki Y, Suzuki H, et al. Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy[J]. PLoS One, 2014, 9(2): e89707.
|
| [18] |
Xie LS, Qin W, Fan JM, et al. The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy [J] . Clin Invest Med, 2010, 33(1): 5-13.
|
| [19] |
Emancipator SN.Prospects and perspectives on IgA nephropathy from animal models[J]．Contrib Nephrol，2011，169：126-152.
|
| [20] |
Kiryluk K, Novak J．The genetics and immunobiology of IgA nephropathy[J]．J Clin Invest, 2014, 124(6): 2325-2332.
|
| [21] |
Ji L, Chen X, Zhong X, et al. Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy.[J]BMC Complement Altern Med, 2014, 14: 195.
|
| [22] |
高植明．黄芪提取物对IgAN患者IgA1异常糖基化的作用及其分子机制研究[J]．北方药学，2016, 13(8): 115-116.
|
| [23] |
沈世忠，杨忠民，蔡佳盈等．黄芪注射液对IgA肾病患者免疫球蛋白分子异常糖基化及Cosmc基因表达的影响[J]．中国老年学杂志，2017, 37(11): 2788-2789.
|
| [24] |
Chen F, Ma YL, Ding H, et al. Effects of tripterygium wilfordii glycosides on regulatory T cells and Th17 in an IgA nephropathy rat model[J]. Genet Mol Res, 2015，14(4)：14900-14907.
|
| [25] |
申鹏霄，赵根尚，吴双，等．雷公藤多甙片对IgA肾病大鼠炎性因子及肾功能的影响[J]．中华实验外科杂志，2017, 34(4): 631-634.
|
| [26] |
朱彩凤，朱斌，包自阳，等．雷公藤内酯醇对IgA肾病大鼠蛋白尿和nephrin、podocin蛋白及mRNA表达的影响[J]．中国中西医结合肾病杂志，2015, (2): 106-109.
|
| [27] |
Li P, Chen YZ, Lin HL, et al. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial[J]. Trials, 2017, 18(1): 170.
|
| [28] |
卢嫣，韩世盛，王怡. 粘膜方对IgA肾病患者外周血B淋巴细胞Comsc表达的影响[J]．中国中西医结合肾病杂志，2016, 17(10): 874-876.
|
| [29] |
周丽霞，熊佩华，费梅，等．活血养阴方对IgA肾病大鼠的治疗作用[J]．中国中西医结合肾病杂志，2015, (8): 674-676.
|
| [30] |
彭亚军，李旭华，何泽云，等．六味地黄汤对IgA肾病大鼠外周血C1 GALT1及Cosmc mRNA表达影响研究[J]．中国中西医结合肾病杂志，2016, 17(3): 211-214.
|
| [31] |
Hastings MC, Moldoveanu Z, Suzuki H，et al.Biomarkers in IgA nephropathy relationship to pathogenetic hits[J]．Expert Opin Med Diagn，2013，7(6)：615-627.
|
| [32] |
Kiryluk K, Moldoveanu Z, Sanders JT，et al.Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis[J]．Kidney Int，2011，80(1)：79-87.
|